Futura Medical Plc Stock Net Income
| FAMDF Stock | USD 0.04 0.03 317.00% |
As of the 9th of February, Futura Medical shows the Mean Deviation of 42.42, coefficient of variation of 554.0, and Downside Deviation of 55.81. Futura Medical plc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Futura Medical plc treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Futura Medical plc is priced favorably, providing market reflects its regular price of 0.0417 per share. As Futura Medical plc appears to be a penny stock we also advise to verify its total risk alpha numbers.
Futura Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Futura Medical's valuation are provided below:Futura Medical plc does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Futura |
Futura Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Futura Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Futura Medical.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Futura Medical on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Futura Medical plc or generate 0.0% return on investment in Futura Medical over 90 days. Futura Medical is related to or competes with Biovaxys Technology, and Ensysce Biosciences. Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcar... More
Futura Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Futura Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Futura Medical plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 55.81 | |||
| Information Ratio | 0.1792 | |||
| Maximum Drawdown | 480.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Futura Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Futura Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Futura Medical's standard deviation. In reality, there are many statistical measures that can use Futura Medical historical prices to predict the future Futura Medical's volatility.| Risk Adjusted Performance | 0.1547 | |||
| Jensen Alpha | 13.08 | |||
| Total Risk Alpha | 5.21 | |||
| Sortino Ratio | 0.2382 | |||
| Treynor Ratio | 3.85 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Futura Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Futura Medical February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1547 | |||
| Market Risk Adjusted Performance | 3.86 | |||
| Mean Deviation | 42.42 | |||
| Semi Deviation | 26.3 | |||
| Downside Deviation | 55.81 | |||
| Coefficient Of Variation | 554.0 | |||
| Standard Deviation | 74.2 | |||
| Variance | 5505.28 | |||
| Information Ratio | 0.1792 | |||
| Jensen Alpha | 13.08 | |||
| Total Risk Alpha | 5.21 | |||
| Sortino Ratio | 0.2382 | |||
| Treynor Ratio | 3.85 | |||
| Maximum Drawdown | 480.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 | |||
| Downside Variance | 3114.35 | |||
| Semi Variance | 691.49 | |||
| Expected Short fall | (130.05) | |||
| Skewness | 3.21 | |||
| Kurtosis | 13.5 |
Futura Medical plc Backtested Returns
Futura Medical is out of control given 3 months investment horizon. Futura Medical plc secures Sharpe Ratio (or Efficiency) of 0.21, which denotes the company had a 0.21 % return per unit of risk over the last 3 months. We were able to break down twenty-seven different technical indicators, which can help you to evaluate if expected returns of 18.03% are justified by taking the suggested risk. Use Futura Medical Downside Deviation of 55.81, coefficient of variation of 554.0, and Mean Deviation of 42.42 to evaluate company specific risk that cannot be diversified away. Futura Medical holds a performance score of 16 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.48, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Futura Medical will likely underperform. Use Futura Medical treynor ratio, expected short fall, day typical price, as well as the relationship between the potential upside and daily balance of power , to analyze future returns on Futura Medical.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Futura Medical plc has insignificant reverse predictability. Overlapping area represents the amount of predictability between Futura Medical time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Futura Medical plc price movement. The serial correlation of -0.18 indicates that over 18.0% of current Futura Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Futura Medical plc reported net income of (4.96 Million). This is 101.45% lower than that of the Healthcare sector and 107.08% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.87% higher than that of the company.
Futura Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Futura Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Futura Medical could also be used in its relative valuation, which is a method of valuing Futura Medical by comparing valuation metrics of similar companies.Futura Medical is currently under evaluation in net income category among its peers.
Futura Fundamentals
| Return On Equity | -0.58 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 157.14 M | |||
| Shares Outstanding | 292.58 M | |||
| Shares Owned By Insiders | 36.03 % | |||
| Shares Owned By Institutions | 34.53 % | |||
| Price To Earning | (7.23) X | |||
| Price To Book | 17.59 X | |||
| Gross Profit | 31.78 K | |||
| EBITDA | (5.85 M) | |||
| Net Income | (4.96 M) | |||
| Cash And Equivalents | 6.68 M | |||
| Cash Per Share | 0.02 X | |||
| Current Ratio | 5.78 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (3.87 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.72 | |||
| Market Capitalization | 189.79 M | |||
| Total Asset | 11.8 M | |||
| Net Asset | 11.8 M |
About Futura Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Futura Medical plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Futura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Futura Medical plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Futura Pink Sheet
Futura Medical financial ratios help investors to determine whether Futura Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Futura with respect to the benefits of owning Futura Medical security.